Home > Research > Publications & Outputs > Immunohistochemical evidence for the derivation...
View graph of relations

Immunohistochemical evidence for the derivation of a peptide ligand from the amyloid β-protein precursor of Alzheimer disease

Research output: Contribution to Journal/MagazineJournal articlepeer-review

  • D Allsop
  • C W Wong
  • S Ikeda
  • M Landon
  • M Kidd
  • G G Glenner
<mark>Journal publication date</mark>1988
<mark>Journal</mark>Proceedings of the National Academy of Sciences of the United States of America
Issue number8
Number of pages5
Pages (from-to)2790-2794
Publication StatusPublished
<mark>Original language</mark>English


A monoclonal antibody to a synthetic peptide consisting of residues 8-17 of the amyloid beta protein of Alzheimer disease was used in immunohistochemical studies to reveal binding sites for this peptide in vesicular elements in the islets of Langerhans of the pancreas and the zona reticularis of the adrenal gland. These binding sites may represent a specific membrane receptor. These results, together with similarities in structural features between the precursors for epidermal growth factor and beta protein, suggest that the beta-protein precursor may be processed to release an active peptide ligand rather than acting as a membrane receptor. In Alzheimer disease, abnormal processing of this active peptide precursor may result in the deposition of beta-protein amyloid fibrils in the brain.